Competency category
Psychological Support and Psychotherapy
Therapeutic alliance, preparation and integration techniques, transference, in-session support, and managing altered states.
239 competencies, 168 with this as their primary category.
Looking for something specific? Ask Blossom
Primary competencies (168)
Competencies whose primary home is this category.
Preparation and integration support
PrimaryCluster covering 31 related competencies including: Integration support, Integration therapy, Integration coaching.
8 care stages · 43 guidelines · 18 courses · 14 providers
5-MeO-DMTDMT / AyahuascaIbogaine+5 moreManualized psychedelic psychotherapy delivery
PrimaryTeaches delivery of psychedelic-assisted psychotherapy according to an approved study manual across preparation, dosing, integration, and follow-up. The competency balances standardized structure with non-directive support for the participant’s therapeutic process.
8 care stages · 25 guidelines · 3 courses · 2 providers
KetamineLSDMDMA+1 morePreparation support
PrimaryCluster covering 11 related competencies including: Preparation support, Psilocybin preparation, Therapeutic preparation.
8 care stages · 16 guidelines · 6 courses · 5 providers
5-MeO-DMTDMT / AyahuascaIbogaine+4 moreSupportive nondirective therapeutic stance
PrimaryCluster covering 6 related competencies including: Therapeutic support during dosing, Nondirective dosing-session presence, Supportive dosing-session facilitation.
7 care stages · 16 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaMDMA+1 moreTherapeutic alliance building
PrimaryCluster covering 2 related competencies including: Therapeutic alliance building, Therapeutic alliance and rapport building.
7 care stages · 15 guidelines · 1 courses · 1 providers
5-MeO-DMTDMT / AyahuascaMDMA+1 morePsilocybin session facilitation
PrimaryCluster covering 9 related competencies including: Psilocybin facilitation, Psilocybin session support, Psilocybin facilitation basics.
8 care stages · 14 guidelines · 6 courses · 5 providers
LSDPsilocybinPsychedelic-assisted psychotherapy preparation and integration
PrimaryTeaches structured pre-dose preparation and post-dose integration as the therapeutic frame for psychedelic-assisted psychotherapy. The therapist supports rapport, intention clarification, meaning-making, emotional processing, and consolidation of insights after dosing.
8 care stages · 13 guidelines · 2 courses · 2 providers
5-MeO-DMTDMT / AyahuascaKetamine+3 moreKetamine psychotherapy delivery
PrimaryCluster covering 12 related competencies including: KAP psychotherapy delivery, Ketamine and KAP knowledge, Ketamine integration planning.
8 care stages · 12 guidelines · 7 courses · 5 providers
KetamineTrauma-informed therapeutic presence and somatic support
PrimaryTeaches a trauma-informed stance during psychedelic work, including calm presence, non-verbal reassurance, body-aware support, somatic orientation, and containment through difficult experiences while maintaining safety and boundaries.
6 care stages · 9 guidelines · 2 courses · 2 providers
KetamineMDMAPsilocybinGrounding and regulation techniques
PrimaryTherapists must be able to teach and coach grounding practices that help participants regulate during preparation and dosing. These methods are used before medication and during distress.
6 care stages · 9 guidelines · 0 courses · 0 providers
MDMAPsilocybinPsychedelic-assisted therapy facilitation
PrimaryCluster covering 2 related competencies including: Psychedelic-assisted therapy facilitation, Group facilitation in a psychedelic setting.
6 care stages · 8 guidelines · 0 courses · 0 providers
DMT / AyahuascaKetamineLSD+2 morePsychological support during altered states
PrimaryProvides supportive therapeutic presence while the patient is under the influence of ketamine. Uses calming, noncoercive guidance to help the patient navigate dissociation and emotional material.
7 care stages · 8 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+3 moreTransference, countertransference, and therapist self-awareness
PrimaryTeaches recognition and management of relational dynamics that can intensify in psychedelic-assisted therapy. Learners develop self-awareness around countertransference, projection, attachment, dependency, and other therapeutic-process risks.
6 care stages · 7 guidelines · 1 courses · 1 providers
5-MeO-DMTKetamineMDMA+1 moreIntegration and post-session debriefing
PrimaryCluster covering 4 related competencies including: Integration and debriefing, Integration and debriefing facilitation, Integration and post-session debriefing.
6 care stages · 6 guidelines · 0 courses · 0 providers
DMT / AyahuascaPsilocybinTherapeutic rapport building
PrimaryCluster covering 4 related competencies including: Therapeutic rapport building, Rapport building and trust development, Therapeutic rapport and trust building.
5 care stages · 6 guidelines · 0 courses · 0 providers
5-MeO-DMTLSDPsilocybinPsilocybin psychotherapy framework
PrimaryCluster covering 4 related competencies including: Psychedelic therapy workflow, Psilocybin psychotherapy framework, Psilocybin-assisted psychotherapy framework.
8 care stages · 5 guidelines · 4 courses · 2 providers
DMT / AyahuascaKetaminePsilocybinSession facilitation and therapeutic holding
PrimaryCluster covering 2 related competencies including: Session facilitation and therapeutic holding, Session facilitation and support during intense experiences.
5 care stages · 5 guidelines · 2 courses · 2 providers
5-MeO-DMTDMT / AyahuascaIbogaine+5 moreFacilitate processing of difficult emotions
PrimaryTherapists must help patients face and work through grief, fear, rage, panic, shame, guilt, and existential distress rather than avoid them. The clinician supports emotional expression while maintaining safety and meaning-making.
4 care stages · 5 guidelines · 0 courses · 0 providers
MDMAPsilocybinKnowledge of PTSD and fear extinction theory
PrimaryUnderstand the clinical and neurobehavioral rationale for PE and exposure-based treatment. The therapist should know how extinction learning is conceptualized in the study model.
4 care stages · 5 guidelines · 0 courses · 0 providers
KetamineMDMATrauma-focused exposure facilitation
PrimaryFacilitate trauma exposure in a structured, supportive, and protocol-consistent manner. The therapist must be able to initiate, pace, and process exposure work while maintaining adherence to PE methods.
5 care stages · 5 guidelines · 0 courses · 0 providers
KetamineMDMAWorking with inner healing intelligence
PrimaryThe course teaches how to work with the 'Inner Healing Intelligence,' indicating a non-directive or facilitative stance toward client-led healing processes. This is framed as a core therapeutic concept in psychedelic work.
4 care stages · 4 guidelines · 1 courses · 1 providers
MDMAFacilitate integration of experience into behavioral change
PrimaryCluster covering 2 related competencies including: Integration of psychedelic experience with behavior change, Facilitate integration of experience into behavioral change.
4 care stages · 4 guidelines · 0 courses · 0 providers
5-MeO-DMTPsilocybinNarrative elicitation and phenomenological listening
PrimaryTherapists must be able to elicit a full account of the dosing experience without overinterpreting it. The goal is to help participants remember, narrate, and reflect on their experience in detail.
3 care stages · 4 guidelines · 0 courses · 0 providers
5-MeO-DMTPsilocybinBalance inner focus with communication
PrimaryTherapists should support an appropriate rhythm between inward experiential focus and verbal interaction, with either therapist or participant able to initiate shifts.
3 care stages · 3 guidelines · 0 courses · 0 providers
DMT / AyahuascaIbogaineMDMAElicit and formulate positive intentions
PrimaryHelp the patient identify personally meaningful, positive intentions to guide the session and future change. Intentions should be active, concrete, and framed toward desired gains rather than avoidance.
2 care stages · 3 guidelines · 0 courses · 0 providers
5-MeO-DMTPsilocybinEmpathic presence and listening
PrimaryTherapists must listen with nonjudgmental, emotionally attuned presence and convey validation, reassurance, and curiosity. They should be able to stay relaxed yet engaged, including noticing nonverbal cues and responding without prying.
3 care stages · 3 guidelines · 0 courses · 0 providers
DMT / AyahuascaMDMAFacilitating insight and peak experiences
PrimaryThe protocol assumes therapeutic value in insight, catharsis, and peak experiences, so the therapist must support conditions that may allow these to emerge safely and meaningfully. This includes recognizing and working with symbolic and transformative material.
2 care stages · 3 guidelines · 0 courses · 0 providers
5-MeO-DMTIbogaineKetamineHandle altered, irrational, or hallucinatory narratives without invalidation
PrimaryAccept the patient’s experience as meaningful without disputing or forcing interpretation. The therapist supports reflection while avoiding premature conclusions about reality or correctness.
3 care stages · 3 guidelines · 0 courses · 0 providers
MDMAMescalinePsilocybinMindfulness instruction
PrimaryFacilitator can teach and cue mindfulness practices consistent with the study protocol. Mindfulness is presented as present-moment, nonjudgmental awareness.
5 care stages · 3 guidelines · 0 courses · 0 providers
KetamineMDMAPsilocybinPractice nondirective, participant-led facilitation
PrimaryA core competency is following rather than steering the participant’s process, intervening only in service of the unfolding inner-directed experience.
2 care stages · 3 guidelines · 0 courses · 0 providers
MDMAPsilocybinPsychological preparation and anxiety reduction
PrimaryFacilitators need practical skills in preparing participants emotionally for ketamine administration and reducing distress. The protocol highlights relaxation, breathing, and grounding strategies to reduce anxiety or discomfort associated with the drug experience.
3 care stages · 3 guidelines · 0 courses · 0 providers
DMT / AyahuascaKetamineSpecial population sensitivity in advanced cancer
PrimaryTailor therapeutic engagement to patients with advanced non-operable GI cancers facing existential distress, grief, and limited life expectancy. The therapist/facilitator must recognize the emotional and medical context of end-of-life suffering.
2 care stages · 3 guidelines · 0 courses · 0 providers
KetamineLSDPsilocybinSupport peak or mystical-type experiences without imposing them
PrimaryFacilitators should be able to contain and make therapeutic use of profound emotional or peak experiences, including ego loosening, awe, reassurance, and feelings of unity or peace. The article suggests these experiences can be highly meaningful and therapeutic, but not all need to meet full mystical criteria.
3 care stages · 3 guidelines · 0 courses · 0 providers
5-MeO-DMTIbogaineLSDTeach and apply stress inoculation and anxiety support
PrimaryTherapists should identify or teach in-session coping tools and collaboratively plan how anxiety states will be recognized and supported.
3 care stages · 3 guidelines · 0 courses · 0 providers
5-MeO-DMTMDMAPsilocybinTherapeutic alliance and trust building
PrimaryThe therapist must create an atmosphere of confidence and mutual understanding before ketamine administration. This relationship is treated as a key therapeutic factor in the protocol.
5 care stages · 3 guidelines · 0 courses · 0 providers
IbogaineKetaminePsilocybinTherapeutic rapport and engagement support
PrimaryHelp patients engage in emotionally intense trauma-focused treatment and reduce dropout risk. The therapist should recognize comorbid depression or anxiety that may interfere with adherence and response.
5 care stages · 3 guidelines · 0 courses · 0 providers
DMT / AyahuascaKetamineMDMAUse clear, participant-centered communication
PrimaryTherapists should communicate in language and nonverbal style the participant can readily follow, avoiding overly theoretical or confusing discourse.
3 care stages · 3 guidelines · 0 courses · 0 providers
5-MeO-DMTMDMAGuided inquiry and reflective language
PrimaryStudents learn to use language and questions that deepen a client’s inner experience and support healing. This is a practical communication competency for facilitation and integration work.
5 care stages · 2 guidelines · 1 courses · 1 providers
LSDMDMAPsilocybinTherapist self-regulation
PrimaryThe curriculum explicitly includes therapist self-regulation as a therapeutic skill. This suggests learners are expected to maintain steadiness and presence while supporting clients in altered states.
3 care stages · 2 guidelines · 1 courses · 1 providers
MDMAPsilocybinACT-based case formulation
PrimaryTherapists must understand participant distress through an Acceptance and Commitment Therapy lens and use that formulation throughout preparation, dosing, and integration. They identify psychological inflexibility processes and track movement toward or away from psychological flexibility.
4 care stages · 2 guidelines · 0 courses · 0 providers
PsilocybinAction planning and relapse-prevention support
PrimaryHelps participants convert motivation into specific behavior-change strategies. Uses structured planning tools and individualized modules to address triggers, coping, and alternative behaviors.
2 care stages · 2 guidelines · 0 courses · 0 providers
KetaminePsilocybinConduct qualitative, client-centered inquiry
PrimaryFacilitators/research therapists should be able to elicit and understand patients’ subjective experience from a client-centered perspective. The study used semi-structured interviews focused on experience, anxiety, quality of life, and values.
2 care stages · 2 guidelines · 0 courses · 0 providers
DMT / AyahuascaLSDDeliver mindfulness and grounding exercises
PrimaryUse brief mindfulness practices and grounding strategies to stabilize attention and reduce distress before and during the session. These techniques help the patient reconnect to present-moment awareness and bodily sensation.
3 care stages · 2 guidelines · 0 courses · 0 providers
DMT / AyahuascaPsilocybinEmpathic presence and active listening
PrimaryTherapists are expected to provide consistent empathic presence, nonjudgmental attunement, and deep listening throughout the process. This includes validating feelings, listening for deeper meaning, and creating psychological permission for openness.
5 care stages · 2 guidelines · 0 courses · 0 providers
IbogaineMDMAFunction effectively as a therapy pair
PrimaryWhere co-therapy is used, therapists should work cohesively, remain present, and respect participant preferences within the dyad.
3 care stages · 2 guidelines · 0 courses · 0 providers
MDMAJudicious use of interpretation
PrimaryTherapists may offer interpretations or insights, but these should be minimized and subordinated to the participant’s own discernment. The model values participant-led meaning making over therapist-imposed explanations.
2 care stages · 2 guidelines · 0 courses · 0 providers
DMT / AyahuascaMDMAMaintain beginner’s mind
PrimaryTherapists should cultivate openness about both the participant’s process and their own interpretations. This prevents forcing experience into rigid theoretical frames and supports curiosity and compassion.
3 care stages · 2 guidelines · 0 courses · 0 providers
MDMAMeaning-making support
PrimaryHelp patients develop coherent, values-consistent meaning from difficult experiences and MDMA session material. Meaning-making is treated as a core ingredient of recovery and post-traumatic growth.
2 care stages · 2 guidelines · 0 courses · 0 providers
IbogaineMDMAMotivational enhancement for quitting
PrimaryElicit and strengthen motivation to quit smoking and remain abstinent. Facilitators use sessions to explore values, reasons for quitting, and treatment commitment.
3 care stages · 2 guidelines · 0 courses · 0 providers
KetaminePsilocybinMotivational interviewing and enhancement
PrimaryUses motivational interviewing methods to strengthen intrinsic motivation and commitment to change. Tailors discussions to the participant’s ambivalence, goals, and readiness to change drinking behavior.
4 care stages · 2 guidelines · 0 courses · 0 providers
KetaminePsilocybinNausea and vomiting management
PrimaryRecognize and respond to gastrointestinal adverse effects that may occur frequently with higher doses. Manage emesis to reduce aspiration risk, dehydration, and treatment disruption.
3 care stages · 2 guidelines · 0 courses · 0 providers
MescalineIbogaineNon-directive facilitation
PrimaryTherapists must facilitate rather than control the participant's process, using invitations and timing interventions carefully. They should preserve the participant-led unfolding of experience while knowing when gentle direction or safety-based assertiveness is needed.
2 care stages · 2 guidelines · 0 courses · 0 providers
DMT / AyahuascaMDMAPE protocol delivery
PrimaryDeliver manualized Prolonged Exposure therapy according to the study protocol and standard PE structure. This includes sequencing psychoeducation, in vivo exposure, imaginal exposure, homework review, and relapse prevention across sessions.
2 care stages · 2 guidelines · 0 courses · 0 providers
KetaminePreparation for altered-state experience
PrimaryA major therapist competency is preparing patients extensively for the ketamine session, including the nature of the special state of consciousness and possible ego dissolution or separation from the body. Preparation is both educational and psychotherapeutic.
3 care stages · 2 guidelines · 0 courses · 0 providers
KetamineMDMARelapse prevention psychotherapy delivery
PrimaryDeliver ongoing relapse prevention psychotherapy after dosing through the post-dose follow-up period. The approach is used to support alcohol recovery and translate treatment effects into behavior change.
4 care stages · 2 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaStress inoculation and breathwork instruction
PrimaryAt least one therapist must be able to teach stress inoculation methods, especially diaphragmatic breathing, and apply breath-based interventions during sessions. Breath is used both for relaxation and for staying present with difficult experience.
4 care stages · 2 guidelines · 0 courses · 0 providers
5-MeO-DMTMDMAUnderstanding MDMA effects and non-linear healing
PrimaryTherapists must have a thorough understanding of MDMA’s subjective, relational, and physiological effects, including the non-linear way these may support healing. This knowledge is necessary for preparation, in-session decisions, and normalization of participant experiences.
4 care stages · 2 guidelines · 0 courses · 0 providers
MDMAUse of ACT and adjunctive psychotherapies
PrimaryApply Acceptance and Commitment Therapy as the primary psychotherapeutic framework, while using other modalities as clinically indicated. The protocol also references CBT, psychodynamic approaches, and Internal Family Systems.
5 care stages · 2 guidelines · 0 courses · 0 providers
KetaminePsilocybinValues clarification and committed action coaching
PrimaryTherapists must help participants identify, recover, and translate values into concrete behavior change. The manual treats values work as central to depression recovery and integration.
4 care stages · 2 guidelines · 0 courses · 0 providers
PsilocybinWork with bodily sensations and somatic process
PrimaryTherapists should orient to and explore the participant’s somatic experience, both in experimental and integrative sessions, as a central channel of processing.
3 care stages · 2 guidelines · 0 courses · 0 providers
MDMAWork with psychodynamic material
PrimaryTherapists need knowledge of psychodynamic processes likely to arise under LSD, including emergence of previously excluded material, abreaction, catharsis, and memory-rich reliving of past experiences. The discussion explicitly identifies these as mechanisms relevant to treatment.
2 care stages · 2 guidelines · 0 courses · 0 providers
LSDIntegration support and meaning-making
PrimaryCluster covering 2 related competencies including: Integration support and meaning-making, Meaning-making and integration support.
3 care stages · 1 guidelines · 4 courses · 4 providers
KetaminePsilocybinTrauma-informed care
PrimaryCluster covering 2 related competencies including: Trauma-informed care, Trauma-informed psychedelic care.
8 care stages · 1 guidelines · 4 courses · 4 providers
KetaminePsilocybinPsychedelic integration support
PrimaryCluster covering 2 related competencies including: Psychedelic integration support, Psychedelic knowledge integration.
5 care stages · 1 guidelines · 2 courses · 2 providers
DMT / AyahuascaPsychotherapeutic facilitation methods
PrimaryCluster covering 2 related competencies including: Facilitation of psychedelic journeys, Psychotherapeutic facilitation methods.
6 care stages · 1 guidelines · 2 courses · 2 providers
LSDPsilocybinPsychedelic harm reduction and integration fundamentals
PrimaryCluster covering 2 related competencies including: Psychedelic harm reduction and integration therapy, Psychedelic harm reduction and integration fundamentals.
5 care stages · 1 guidelines · 2 courses · 1 providers
KetamineLSDMDMA+1 moreTrauma-informed practice
PrimaryCluster covering 2 related competencies including: Trauma-informed practice, Trauma-informed clinical practice.
7 care stages · 1 guidelines · 2 courses · 1 providers
MDMAPsilocybinUse of adjunctive therapeutic modalities
PrimaryAdvanced trainings mention topics like IFS, art therapy, breathwork, and integration, implying learners can deepen their practice with complementary methods. These are presented as continuing development topics rather than core prerequisites.
3 care stages · 1 guidelines · 1 courses · 1 providers
IbogaineACT-informed psychoeducation and skills teaching
PrimaryTherapists teach ACT concepts in a way that helps participants recognize depression-related patterns and build psychological flexibility. The manual expects direct instruction plus experiential learning.
1 care stage · 1 guidelines · 0 courses · 0 providers
PsilocybinActive listening micro-skills
PrimaryTherapists are expected to use concrete active listening skills that support exploration without overdirecting. These communication skills help maintain emotional safety and participant agency.
1 care stage · 1 guidelines · 0 courses · 0 providers
MDMAAlcohol use disorder clinical knowledge
PrimaryHave a working understanding of moderate to severe AUD, relapse processes, craving, withdrawal, and common comorbidities. This knowledge is required to deliver the integrated treatment model safely and effectively.
3 care stages · 1 guidelines · 0 courses · 0 providers
5-MeO-DMTAssess and prepare social support
PrimaryTherapists should evaluate the participant’s support network and help plan how supports can assist between sessions. They must also guide participants about the benefits and risks of disclosing their experiences to others.
3 care stages · 1 guidelines · 0 courses · 0 providers
MDMAAssessment-related participant support
PrimaryTherapists and study staff must manage participant distress and fatigue associated with questionnaires and interviews. Competence includes pacing, offering breaks, and responding supportively to emotionally evocative content.
2 care stages · 1 guidelines · 0 courses · 0 providers
PsilocybinAttachment and continuing bonds work
PrimaryTherapists must facilitate reconstructing the internal representation of the deceased and the ongoing bond with them. This includes work on unfinished business, communication, and secure attachment-related meaning.
1 care stage · 1 guidelines · 0 courses · 0 providers
DMT / AyahuascaAuthenticity and trustworthiness
PrimaryFacilitators should present as authentic, relatable, and trustworthy, and be open to participant questions and feedback. Establishing a credible and safe relational basis is part of responsible practice.
2 care stages · 1 guidelines · 0 courses · 0 providers
5-MeO-DMTBackground in trauma psychotherapy
PrimaryTherapists should have substantial background in PTSD treatment and related trauma modalities. Experience with multiple evidence-based and adjunctive approaches supports flexible understanding of what may arise in MDMA sessions.
1 care stage · 1 guidelines · 0 courses · 0 providers
MDMABehavioral treatment competence
PrimaryThe protocol implies competence in evidence-based behavioral smoking cessation methods, including cognitive-behavioral approaches. Facilitators should be able to apply these methods in combination with psilocybin treatment.
1 care stage · 1 guidelines · 0 courses · 0 providers
PsilocybinCBT expertise for mood disorders
PrimaryClinicians must have working expertise in evidence-based CBT for depression and related mood conditions, including the ability to deliver core CBT components across preparation, post-session integration, and relapse prevention phases. The protocol assumes competence in standard CBT delivery as the psychosocial backbone of treatment.
4 care stages · 1 guidelines · 0 courses · 0 providers
PsilocybinCheck-in and timing of interventions during sessions
PrimaryTherapists must skillfully time check-ins and interventions to sustain process without unnecessary intrusion. They monitor silence, talking, avoidance, and signs of internal engagement to decide when to inquire, redirect, or simply witness.
3 care stages · 1 guidelines · 0 courses · 0 providers
MDMACognitive-behavioral smoking cessation counseling
PrimaryDeliver structured CBT-based smoking cessation support throughout the trial. Facilitators teach practical self-management strategies before and after the target quit date.
2 care stages · 1 guidelines · 0 courses · 0 providers
PsilocybinCollaborative choice-making
PrimaryWork collaboratively with the patient, sharing observations and options while preserving the patient’s authority over their process. This supports empowerment in the context of trauma-related loss of control.
1 care stage · 1 guidelines · 0 courses · 0 providers
MDMACollaborative therapeutic dialogue
PrimaryThe therapist must engage patients in dialogue rather than one-way instruction, building meaning collaboratively. This includes discussing motives, goals, beliefs about addiction, and consequences of drug use.
1 care stage · 1 guidelines · 0 courses · 0 providers
KetamineCollaboratively address trauma material
PrimaryTherapists should obtain agreement that trauma may be gently brought up if not spontaneously addressed, while preserving participant choice and collaborative exploration.
1 care stage · 1 guidelines · 0 courses · 0 providers
MDMACombination risk awareness
PrimaryFacilitators must know that combining 5-MeO-DMT with other psychoactives or MAO-inhibitors can be dangerous or fatal. Careful pacing and separation from other substances are necessary.
2 care stages · 1 guidelines · 0 courses · 0 providers
DMT / Ayahuasca5-MeO-DMTConfidential, respectful handling of subjective disclosures
PrimaryTreat participant disclosures during interviews and integration as sensitive clinical information. The facilitator should elicit and document experiences respectfully and without judgment.
1 care stage · 1 guidelines · 0 courses · 0 providers
5-MeO-DMTControlled inhalation administration
PrimaryCan safely administer vaporized GH001 using standardized equipment and procedure. Accurate delivery and participant instruction are essential to reliable dosing.
2 care stages · 1 guidelines · 0 courses · 0 providers
5-MeO-DMTCultivate beginner’s mind
PrimaryTherapists should encourage participants to set aside rigid expectations and remain open to whatever arises during experimental sessions.
1 care stage · 1 guidelines · 0 courses · 0 providers
MDMAElicit expectations, fears, and concerns
PrimaryTherapists should proactively explore participants’ hopes, fears, concerns, and expectations about treatment and address them responsively.
1 care stage · 1 guidelines · 0 courses · 0 providers
MDMAEmpathic sensitivity and nonverbal attunement
PrimaryThe handbook expects therapists to perceive and respond to the subject’s feeling state with heightened empathy, especially when verbal communication is reduced. This is particularly emphasized in individual sessions and in group work where nonverbal emotional communication becomes prominent.
1 care stage · 1 guidelines · 0 courses · 0 providers
LSDEnable perspective shift and de-schematization
PrimaryFacilitators should help patients use altered states to reconsider entrenched beliefs, habits, and self-referential frames. The paper describes LSD as promoting new perspectives, broader contextualization, and re-evaluation of illness, self, and life priorities.
1 care stage · 1 guidelines · 0 courses · 0 providers
LSDEthical use of reassurance
PrimaryProvide reassurance when it helps establish safety, while avoiding invalidation or minimization. Reassurance should support rather than dismiss the patient’s experience.
1 care stage · 1 guidelines · 0 courses · 0 providers
MDMAExistential psychotherapy orientation
PrimaryThe therapist needs knowledge of existentially oriented psychotherapy and how to apply it in addiction treatment. The protocol explicitly frames KPT around meaning, values, self-concept, and life purpose.
1 care stage · 1 guidelines · 0 courses · 0 providers
KetamineFacilitate access to emotions and catharsis
PrimaryA central therapeutic skill is helping patients safely enter, tolerate, and process intensified emotions that emerge during LSD sessions. The study highlights facilitated access to emotions, catharsis, crying, grief work, and relief after expression.
1 care stage · 1 guidelines · 0 courses · 0 providers
LSDFacilitate post-session reflection and home practices
PrimaryTherapists should guide participants toward practices that support reflection, grounding, and continuing integration between visits. These activities extend the therapeutic process beyond formal sessions.
2 care stages · 1 guidelines · 0 courses · 0 providers
MDMAFocused bodywork competence
PrimaryFocused bodywork is an optional advanced intervention used to facilitate release of blocked emotion or somatic tension when spontaneous processing has stalled. Therapists need specific judgment and skill to apply it safely and only when indicated.
1 care stage · 1 guidelines · 0 courses · 0 providers
MDMAHandling rationalization and resistance
PrimaryA major therapist task is detecting and not reinforcing rationalizations that protect the existing self-concept. The handbook portrays resistance as subtle and expects the therapist to respond firmly but without hostility.
1 care stage · 1 guidelines · 0 courses · 0 providers
LSDHelp patients generalize new coping responses
PrimaryTherapists must teach patients to reactivate the acceptance, reduced fear, and interpersonal openness experienced during MDMA sessions when confronting later stressors. This helps convert acute session experiences into durable coping skills.
1 care stage · 1 guidelines · 0 courses · 0 providers
MDMAIdentify early improvement and dropout risk during PE
PrimaryThe study examines whether early improvement during PE relates to dropout rates, implying a competency in recognizing early response patterns and engagement risk. Therapists should monitor participation closely and intervene to support retention when possible.
2 care stages · 1 guidelines · 0 courses · 0 providers
KetamineIdentity and values reconstruction
PrimaryFacilitators must support the bereaved person in rebuilding identity and future orientation after loss. The protocol uses values clarification to help participants orient life around their own goals and surviving self.
1 care stage · 1 guidelines · 0 courses · 0 providers
DMT / AyahuascaIn-session emotional support
PrimaryDuring ketamine administration, the therapist provides continuous emotional support while the patient reclines with eyeshades and music. This support helps the patient tolerate and make use of the psychedelic experience.
2 care stages · 1 guidelines · 0 courses · 0 providers
KetamineInstill trust in the healing process
PrimaryTherapists should orient participants to the healing model by conveying trust in the therapeutic process and the participant’s innate capacity for healing.
1 care stage · 1 guidelines · 0 courses · 0 providers
MDMAIntegrate experiences into daily life change
PrimaryTherapists should help patients carry session experiences into durable changes in habits, relationships, values, and quality of life. Reported lasting effects included reduced anxiety, increased openness, patience, boundaries, and shifts in priorities.
2 care stages · 1 guidelines · 0 courses · 0 providers
LSDIntegrated pain-psychiatric care
PrimaryWorks with the combined clinical picture of chronic pain, depression, anxiety, and PTSD symptoms. Provides psychotherapy that is responsive to both somatic and psychiatric suffering.
2 care stages · 1 guidelines · 0 courses · 0 providers
KetamineKnow the therapeutic model and theoretical framework
PrimaryTherapists are trained in the specific model used in the trial, informed by Perceptual Control Theory and related evidence-based approaches. This framework guides how therapists understand participant experience and choose interventions.
1 care stage · 1 guidelines · 0 courses · 0 providers
PsilocybinKnowledge of reaction types and stages
PrimaryTherapists are expected to understand common features, characteristic reaction types, and sequential stages of the experience, because guidance differs by phase. The handbook repeatedly links competency to recognizing where the subject is in the process.
1 care stage · 1 guidelines · 0 courses · 0 providers
LSDManage challenges with letting go and self-control
PrimaryTherapists must help patients navigate early-session resistance, distrust, and discomfort related to surrendering usual control. Several participants reported temporary difficulty letting go or tolerating altered self-control.
1 care stage · 1 guidelines · 0 courses · 0 providers
LSDManaging self-examination and core therapeutic work
PrimaryThe therapist must support the subject through difficult self-scrutiny without taking over the process, distracting prematurely, or colluding with avoidance. This phase is described as the central therapeutic component where emotional insight and acceptance emerge.
1 care stage · 1 guidelines · 0 courses · 0 providers
LSDMeaning reconstruction therapy delivery
PrimaryTherapists must competently deliver the 9-session meaning reconstruction protocol for grief, including its event story, back story, and personal story phases. The work is aimed at helping bereaved participants make sense of the loss, revise attachment-related meanings, and reconstruct identity and future orientation.
2 care stages · 1 guidelines · 0 courses · 0 providers
DMT / AyahuascaMindfulness-based intervention knowledge
PrimaryFacilitator must know the conceptual basis and components of MORE. The protocol links mindfulness, savoring, and reappraisal to changes in craving and reward processing.
1 care stage · 1 guidelines · 0 courses · 0 providers
KetamineMindfulness-based stress reduction facilitation
PrimaryAble to deliver or support an 8-week MBSR curriculum for clinical populations. This requires knowledge of mindfulness practices and the ability to adapt them to frontline healthcare providers experiencing depression and burnout.
1 care stage · 1 guidelines · 0 courses · 0 providers
PsilocybinMonitoring depressive aftermath and unmet integration
PrimaryThe therapist should watch for depression after the experience, particularly when insights are not translated into action. Continued support is presented as a way to reduce this risk and restore constructive orientation.
3 care stages · 1 guidelines · 0 courses · 0 providers
LSDMonitoring psychological defenses and change processes
PrimaryAbility to observe and interpret defense mechanisms and other psychological processes during therapy. This is implied by the MeSH term 'Defense Mechanisms' and psychotherapy context.
1 care stage · 1 guidelines · 0 courses · 0 providers
LSDMORE delivery
PrimaryFacilitator can deliver Mindfulness-Oriented Recovery Enhancement (MORE) in an 8-week group format for patients with OUD. The intervention combines mindfulness training, cognitive reappraisal, and savoring techniques.
1 care stage · 1 guidelines · 0 courses · 0 providers
KetamineMotivational interviewing
PrimaryUses an open, collaborative MI style to engage participants and support change. Employs reflective listening, eliciting change talk, and reinforcing motivation without confrontation.
1 care stage · 1 guidelines · 0 courses · 0 providers
PsilocybinNarrative processing of grief
PrimaryFacilitators need skill in helping bereaved individuals revisit and process the story of the loss in a tolerable and organized way. This includes working with traumatic or stressful memories while keeping the setting emotionally safe.
1 care stage · 1 guidelines · 0 courses · 0 providers
DMT / AyahuascaNonjudgmental addiction care
PrimaryProvides patient-centered, nonjudgmental care to individuals with severe opioid use disorder, including those who have not benefited from conventional treatment. The report’s focus on a treatment-refractory patient implies the need for a supportive, stigma-free approach.
1 care stage · 1 guidelines · 0 courses · 0 providers
IbogaineOnset-phase reassurance and symptom redirection
PrimaryDuring onset, therapists must help the subject stay relaxed, accept changes, and avoid fixation on somatic discomfort or irrelevant ideation. Music and reassurance are highlighted as practical tools for reducing fear and helping the subject welcome altered perception.
1 care stage · 1 guidelines · 0 courses · 0 providers
LSDParanoia and psychotomimetic state management
PrimaryThe therapist must recognize confusion, paranoia, referential thinking, withdrawal, or grandiosity and respond with steady trust, containment, and continued presence. Management skill is particularly important because these reactions may still be workable and may shift with proper handling.
1 care stage · 1 guidelines · 0 courses · 0 providers
LSDPlacebo and expectancy awareness
PrimaryRecognize that placebo response can be substantial in depression trials and that supportive care may amplify expectancy effects. Facilitators should avoid unintentionally inflating suggestibility beyond the protocol.
1 care stage · 1 guidelines · 0 courses · 0 providers
DMT / AyahuascaPossess relevant clinical training and experiential understanding
PrimaryTherapists should have standard training in psychotherapy for anxiety associated with medical illness and would benefit substantially from personal familiarity with non-ordinary states of consciousness. Such understanding improves empathy, confidence, and process navigation.
2 care stages · 1 guidelines · 0 courses · 0 providers
MDMAPractitioner background verification
PrimaryThe facilitator should be able to clearly describe their history, experience, and specific approach with 5-MeO-DMT or related sacramental work. Participants should be able to assess whether the practitioner’s background, lineage, or training is appropriate for their needs.
1 care stage · 1 guidelines · 0 courses · 0 providers
DMT / Ayahuasca5-MeO-DMTPre-onset psychological set management
PrimaryBefore symptoms begin, the therapist must prevent boredom, over-monitoring for effects, and escalating apprehension. This phase is treated as crucial because the psychological set established here shapes much of what follows.
2 care stages · 1 guidelines · 0 courses · 0 providers
LSDPreparation for ketamine sessions
PrimaryTherapists must prepare participants psychologically and practically for ketamine dosing through rapport-building, psychoeducation, expectation-setting, and intention development. Preparation is emphasized because of trauma burden, psychiatric comorbidity, and instability in the target population.
3 care stages · 1 guidelines · 0 courses · 0 providers
KetamineProvide structured psychological support alongside treatment
PrimaryAll patients in the trial received psychological support in conjunction with medication administration, indicating that facilitators must be able to deliver structured supportive care as part of the treatment model.
2 care stages · 1 guidelines · 0 courses · 0 providers
PsilocybinPsychology- and resilience-informed curriculum delivery
PrimaryFacilitators need knowledge of a structured curriculum informed by psychology and resilience science. They must be able to teach and reinforce core resilience factors and translate them into experiential group practices.
1 care stage · 1 guidelines · 0 courses · 0 providers
KetamineRecognition of participant functional status and recovery
PrimaryFacilitators should understand that treatment aims include symptom reduction and improved functioning. Support work should attend to both emotional processing and real-world disability.
2 care stages · 1 guidelines · 0 courses · 0 providers
PsilocybinRelapse-prevention support
PrimaryHelp patients navigate craving, relapse risk, and post-treatment vulnerability. The manual notes that fear of relapse is more realistic than fear of withdrawal after ibogaine.
3 care stages · 1 guidelines · 0 courses · 0 providers
IbogaineRelational field attunement
PrimaryAttend closely to the therapeutic relationship as an active part of the healing process. IMAP treats the relational field as a primary site where trauma, repair, trust, and connection unfold.
1 care stage · 1 guidelines · 0 courses · 0 providers
MDMAStructured smoking cessation treatment delivery
PrimaryFacilitators must be able to deliver psilocybin only as an adjunct within a structured 15-week smoking cessation protocol rather than as a standalone intervention. This requires integrating psychedelic sessions with established tobacco cessation treatment methods.
2 care stages · 1 guidelines · 0 courses · 0 providers
PsilocybinSUDS-guided exposure monitoring
PrimaryUse Subjective Units of Distress Scale ratings to track fear activation and extinction during PE sessions. This requires eliciting reliable distress ratings and using them to guide exposure processing.
2 care stages · 1 guidelines · 0 courses · 0 providers
KetamineSupport confrontation with existential anxiety
PrimaryTherapists should be able to help patients face anxiety, fear of death, hopelessness, and suffering associated with life-threatening illness. The treatment context explicitly targets existential distress and uses LSD sessions to engage these themes.
1 care stage · 1 guidelines · 0 courses · 0 providers
LSDSupport emotional expression and catharsis
PrimaryTherapists must be comfortable with powerful affect and able to support its expression without becoming reactive or controlling. Their role includes normalizing, containing, and encouraging tears, sounds, movement, and other forms of emotional release.
1 care stage · 1 guidelines · 0 courses · 0 providers
MDMASupport for multiplicity without pathologizing
PrimaryTherapists should understand multiplicity of the psyche as a normal phenomenon that may become more apparent in trauma treatment and altered states. They must respond with curiosity and support rather than pathologizing parts, selves, or dissociative phenomena unless clinically necessary.
1 care stage · 1 guidelines · 0 courses · 0 providers
MDMASupport for multiplicity/parts
PrimaryTherapists must understand that parts, selves, subpersonalities, or dissociative-like multiplicity can emerge normally, especially in trauma. They should not pathologize these experiences and should help use them therapeutically.
1 care stage · 1 guidelines · 0 courses · 0 providers
MDMASupport for spontaneous somatic expression
PrimaryParticipants may express the medicine through shaking, curling, dancing, screaming, glossolalia, orgasm, or other intense bodily responses. The facilitator should recognize these as possible natural responses and support them appropriately.
1 care stage · 1 guidelines · 0 courses · 0 providers
5-MeO-DMTSupport positive and corrective emotional experiences
PrimaryTherapists must also recognize and deepen beneficial states such as joy, self-affirmation, resolution, empathy, forgiveness, and acceptance. These experiences are treated as therapeutically important, not merely incidental.
1 care stage · 1 guidelines · 0 courses · 0 providers
MDMASupportive presence selection and visibility
PrimaryFacilitators should adapt their visibility and distance to best support the participant, sometimes being visually present and sometimes minimizing their presence. The goal is to provide reassurance without becoming the focus of attachment.
1 care stage · 1 guidelines · 0 courses · 0 providers
5-MeO-DMTSupportive-expressive psychedelic psychotherapy
PrimaryTherapists must be able to help participants confront, tolerate, and work through intense experiences rather than prematurely suppress them. The method emphasizes support, reassurance, emotional processing, and integration of meaningful material.
2 care stages · 1 guidelines · 0 courses · 0 providers
LSDTask instruction and coaching
PrimaryPrepare participants to complete emotional processing tasks and questionnaires accurately. Staff must teach task procedures and ensure participants understand expectations before scanning and follow-up assessments.
3 care stages · 1 guidelines · 0 courses · 0 providers
PsilocybinTherapeutic treatment planning
PrimaryAbility to plan and structure treatment for patients receiving LSD-assisted psychotherapy. The clinician must organize sessions, timing, and therapeutic objectives appropriately.
1 care stage · 1 guidelines · 0 courses · 0 providers
LSDTiming and calibration of interventions
PrimaryA key applied skill is knowing when to remain silently present, when to inquire, and when to offer more active guidance. Effective work depends on moment-to-moment attunement to verbal, nonverbal, historical, and pharmacological cues.
1 care stage · 1 guidelines · 0 courses · 0 providers
MDMATrack verbal and nonverbal cues
PrimaryTherapists must closely attend to the patient's speech, affect, movement, silence, and bodily signs to understand process and determine appropriate intervention. Fine-grained observation is necessary for both safety and therapeutic timing.
1 care stage · 1 guidelines · 0 courses · 0 providers
MDMATreat all emergent material as therapeutically relevant
PrimaryTherapists should respond as though whatever arises in session—pleasant, difficult, peripheral, symbolic, or practical—may have relevance to healing.
1 care stage · 1 guidelines · 0 courses · 0 providers
MDMAUnderstand psilocybin-assisted therapy as a rapid-acting intervention for depression
PrimaryFacilitators require knowledge of the therapeutic context, including that psilocybin is being investigated as a rapid-acting treatment for major depressive disorder. This includes understanding the expected timeframe of symptom assessment and response.
2 care stages · 1 guidelines · 0 courses · 0 providers
PsilocybinUnderstanding of grief and PGD
PrimaryFacilitators need conceptual knowledge of normal grief, prolonged grief disorder, and the rationale for preventive and therapeutic grief care. This informs formulation, pacing, and risk awareness in the protocol.
2 care stages · 1 guidelines · 0 courses · 0 providers
DMT / AyahuascaUse clinical judgment for intervention timing
PrimaryTherapists must skillfully decide when to facilitate, when to redirect, and when to silently witness. Effective treatment requires balancing guidance with respect for the patient’s self-directed inner healing process.
1 care stage · 1 guidelines · 0 courses · 0 providers
MDMAUse of discussion to consolidate insight
PrimaryOnce stabilization is achieved, the therapist should help the subject translate diffuse feeling states into articulated ideas without imposing doctrinal answers. Discussion is used to deepen learning, interpersonal understanding, and future application.
1 care stage · 1 guidelines · 0 courses · 0 providers
LSDUse self-directed enquiry
PrimaryHelp participants direct attention to their own present-moment internal experience and explore it from multiple perspectives. This is practiced in preparation and used to support participants if challenging material emerges during dosing.
3 care stages · 1 guidelines · 0 courses · 0 providers
PsilocybinValidate affirming experiences as healing
PrimaryTherapists should validate positive, affirming, and resourcing experiences as meaningful components of healing, growth, and meaning-making.
3 care stages · 1 guidelines · 0 courses · 0 providers
MDMAValidate difficult experiences as healing
PrimaryTherapists should frame difficult emotions, challenging material, and distressing experiences as potentially meaningful parts of healing rather than signs of failure.
2 care stages · 1 guidelines · 0 courses · 0 providers
MDMAWork skillfully with resistance and protective mechanisms
PrimaryTherapists should respect defenses, protectors, and resistance as potentially adaptive rather than obstacles to be forcibly overcome. The skill lies in fostering awareness and curiosity about protection while minimizing retraumatization.
1 care stage · 1 guidelines · 0 courses · 0 providers
MDMAWork with emotion regulation and cognitive schemas
PrimaryTherapists should understand and address cognitive-affective mechanisms linked to improvement, particularly emotion regulation and positive and negative cognitive schemas. The study associated symptom improvement with changes in these domains.
1 care stage · 1 guidelines · 0 courses · 0 providers
PsilocybinCase-based practice, peer consultation, and professional learning community
PrimaryTeaches applied competence through role play, case discussion, peer consultation, seminars, mentorship, and learning-community structures. The emphasis is translating theory into practice, receiving feedback, and developing reflective clinical judgment with peers.
8 care stages · 0 guidelines · 8 courses · 7 providers
KetaminePsilocybinExperiential Learning and Reflective Practice
PrimaryTeaches practitioners to use experiential exercises, embodied awareness, supervision, and structured self-reflection to examine their own reactions, assumptions, limits, and relational patterns in clinical work.
3 care stages · 0 guidelines · 2 courses · 2 providers
Preparation and therapeutic alliance
PrimaryCluster covering 2 related competencies including: Preparation and therapeutic alliance, Preparation and therapeutic alliance building.
5 care stages · 0 guidelines · 2 courses · 2 providers
Active guiding and purposeful intervention
PrimaryThe course also teaches a more active guiding style, especially through Ralph Metzner’s approach, where guides may introduce focused inquiries, somatic practices, or other interventions. Learners are shown how interventions can shape the trajectory of a session when used skillfully.
3 care stages · 0 guidelines · 1 courses · 1 providers
Contemplative practice support
PrimaryContemplative practice is included as a core domain, suggesting learners are exposed to practices that support presence, reflection, and self-regulation in facilitation work. This likely supports both practitioner preparation and client-facing care.
4 care stages · 0 guidelines · 1 courses · 1 providers
Expanded-state therapeutic skills
PrimaryThe course explicitly teaches techniques for working with patients in altered states, including grounding, breathwork, and mindfulness. These are presented as tools for supporting expanded and ordinary states of consciousness.
2 care stages · 0 guidelines · 1 courses · 1 providers
KetamineLeadership and coaching presence in expanded states
PrimaryFaculty and program structure emphasize leadership, coaching presence, and personal transformation as part of practitioner development. Students are expected to become more skillful in guiding high-achieving and growth-oriented clients.
4 care stages · 0 guidelines · 1 courses · 1 providers
Observing and holding space without reacting
PrimaryLearners are expected to develop the ability to witness clients and processes calmly, without overreacting or trying to control the experience. The course explicitly frames this as foundational to practitioner development.
4 care stages · 0 guidelines · 1 courses · 1 providers
Peer-informed clinical judgment
PrimaryThe course emphasizes learning from experienced trainers and a community of peers, suggesting development of clinical judgment through discussion, feedback, and shared practice. This is framed as part of building competence in an evolving field.
1 care stage · 0 guidelines · 1 courses · 1 providers
Supervised experiential practice
PrimaryA defining feature of the training is hands-on experiential practice in both non-substance and substance-based modalities under supervision. Learners practice patient and therapist roles, facilitating and undergoing sessions in a structured learning context.
5 care stages · 0 guidelines · 1 courses · 1 providers
PsilocybinSupervised practicum and feedback integration
PrimaryStudents complete 50 supervised practicum hours and receive expert feedback while working with real clients. This is intended to translate theory into competent applied practice.
7 care stages · 0 guidelines · 1 courses · 1 providers
Therapeutic technique enhancement
PrimaryVital says learners will expand their skills and enhance therapeutic techniques. This suggests training in improving how they support clients in psychedelic-related therapeutic work.
4 care stages · 0 guidelines · 1 courses · 1 providers
Tracking nervous systems and consent dynamics
PrimaryThe Colorado practicum site explicitly teaches relational competence, including tracking nervous systems, power, and consent dynamics moment by moment. This is presented as a core facilitation capability.
4 care stages · 0 guidelines · 1 courses · 1 providers
PsilocybinUse of complementary support methods
PrimaryStudents explore how psychedelics can be integrated with supportive methods such as breathwork, meditation, cold therapy, and neurofeedback. The course emphasizes a holistic toolkit rather than a single-method approach.
4 care stages · 0 guidelines · 1 courses · 1 providers
Therapeutic support in patient care settings
PrimaryThe page highlights extensive patient care experience and a background in holistic counseling psychology, suggesting practical competence in supporting participants in clinical or care environments. This is more general care-setting competence than protocol-specific technique.
4 care stages · 0 guidelines · 0 courses · 1 providers
General psychedelic-assisted practice skills
PrimaryCatch-all cluster covering 189 general competencies for psychedelic-assisted clinical practice that did not group into a more specific category — including miscellaneous facilitation, monitoring, ethics, safety, regulatory awareness, group support, and program-specific skills not captured by dedicated clusters elsewhere.
8 care stages · 45 guidelines · 27 courses · 18 providers
5-MeO-DMTDMT / AyahuascaIbogaine+5 more
Also mapped here (71)
Competencies that touch this category as a secondary axis.
Adverse effects and side-effect management
Teaches recognition and management of expected and unexpected side effects during psychedelic or ketamine treatment. The competency emphasizes active observation, supportive response, and clinical escalation when symptoms exceed routine tolerability.
6 care stages · 14 guidelines · 1 courses · 1 providers
DMT / AyahuascaIbogaineKetamine+3 moreMindfulness, intention-setting, set and setting, and somatic presence
Teaches practices that support preparation and therapeutic presence, including mindfulness, intention-setting, body-aware attention, environmental preparation, mindset awareness, and regulation through somatic presence.
7 care stages · 9 guidelines · 7 courses · 6 providers
5-MeO-DMTDMT / AyahuascaIbogaine+4 moreTraining and competency maintenance
Therapists and study personnel are expected to receive structured training and ongoing supervision. Competence includes both protocol adherence and the ability to work safely and consistently across sites.
6 care stages · 8 guidelines · 0 courses · 0 providers
MDMAPsilocybinClinical interviewing and history-taking
Therapists and study clinicians perform detailed biopsychosocial interviewing during preparation and screening. This supports treatment planning, risk assessment, and therapeutic understanding.
5 care stages · 7 guidelines · 0 courses · 0 providers
KetamineMDMAPsilocybinCultural and spiritual sensitivity
Responds respectfully to spiritual, mystical, and value-related themes that may arise during psilocybin sessions and debriefing. Integrates these themes into therapy without imposing interpretations.
3 care stages · 6 guidelines · 0 courses · 0 providers
IbogaineMDMAPsilocybinMusic and therapist-variable awareness
The course explicitly mentions the role of music and therapist variables in treatment. Learners are expected to understand how these elements influence the PAP experience and therapeutic outcome.
5 care stages · 4 guidelines · 1 courses · 1 providers
KetamineMDMANonintrusive session monitoring and containment
Facilitators must balance active safety monitoring with minimal interference in the participant’s inner experience. The role includes maintaining continuous presence, periodic check-ins, and preserving the therapeutic container of the session.
4 care stages · 4 guidelines · 0 courses · 0 providers
DMT / AyahuascaIbogaineMDMA+1 morePsilocybin psychoeducation
Cluster covering 2 related competencies including: Psilocybin psychoeducation, Psychedelic psychoeducation and expectation management.
6 care stages · 4 guidelines · 0 courses · 0 providers
MDMAPsilocybinInformed consent and treatment briefing
Therapists/facilitators must support ethically valid informed consent by ensuring participants understand the intervention, expectations, risks, and logistics. They also provide anticipatory guidance before ketamine sessions and discharge information after dosing.
3 care stages · 3 guidelines · 0 courses · 0 providers
DMT / AyahuascaIbogaineKetamineInformed preparation and orientation of the subject
The therapist is responsible for giving truthful, individualized preparation and reassurance about the experience, including likely sensations, risks of resistance, and expectations for conduct. The preparation aims to reduce fear, improve cooperation, and support voluntary participation.
4 care stages · 3 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaLSDPsychoeducation about MDMA effects and session trajectory
Therapists must understand MDMA’s expected subjective, interpersonal, and physiological effects and prepare participants accordingly. This knowledge supports normalization, reassurance, and effective use of the medicine within therapy.
4 care stages · 3 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaMDMATrauma treatment background
Therapists need a solid professional background in psychotherapy, especially PTSD treatment. Prior experience with established trauma therapies and related approaches is considered important preparation for this work.
4 care stages · 3 guidelines · 0 courses · 0 providers
MDMADosing-day facilitation
Cluster covering 2 related competencies including: Dosing-day facilitation, Dosing-session facilitation.
4 care stages · 2 guidelines · 2 courses · 2 providers
DMT / AyahuascaKetaminePsilocybinAssess and engage support systems
Therapists should understand the participant’s support network and appropriately involve support persons when relevant and desired.
5 care stages · 2 guidelines · 0 courses · 0 providers
MDMAAssessment of emotional stability after sessions
Therapists must remain with participants at the end of and immediately after experimental sessions until emotional stability is established. This requires real-time clinical judgment about readiness for reduced supervision.
3 care stages · 2 guidelines · 0 courses · 0 providers
DMT / AyahuascaMDMAAssessment-driven therapeutic tailoring
Uses assessment findings to individualize therapy and medication-session preparation. Adapts the approach based on participant response, goals, and clinical presentation.
4 care stages · 2 guidelines · 0 courses · 0 providers
KetaminePsilocybinCeremonial framing and intentional therapeutic setting
Facilitators require skill in establishing ceremonial and intentional framing around ketamine sessions to support therapeutic depth and coherence. This includes preparing participants for the significance and structure of the experience within the group model.
3 care stages · 2 guidelines · 0 courses · 0 providers
KetamineConfidential and nonjudgmental therapeutic stance
Facilitators should create a safe interpersonal environment conducive to disclosure and processing. The setting is intentionally designed to support openness, comfort, and trust.
3 care stages · 2 guidelines · 0 courses · 0 providers
DMT / AyahuascaPsilocybinCoordination with community recovery supports
For alcohol use problems, the handbook expects therapists to connect subjects with Alcoholics Anonymous and similar social supports, framing the psychedelic experience as an introduction rather than a cure. This is a competency in continuing care planning.
2 care stages · 2 guidelines · 0 courses · 0 providers
IbogaineLSDExperience with altered states of consciousness
Facilitators are expected to have substantial prior experience supporting altered states of consciousness. This experience supports containment, trust, and skilled response to unusual perceptual and emotional phenomena.
2 care stages · 2 guidelines · 0 courses · 0 providers
DMT / AyahuascaGroup facilitation and relationship management
When leading group sessions, therapists must manage group size, relational instability, empathic bonds, exclusion dynamics, and mutual support among therapists. The handbook treats group structure as a clinically important variable.
2 care stages · 2 guidelines · 0 courses · 0 providers
5-MeO-DMTLSDManagement of assessment-related distress
Because interviews and questionnaires may provoke emotional reactions or fatigue, facilitators must respond supportively and mitigate burden. This includes addressing distress during assessments and offering breaks.
4 care stages · 2 guidelines · 0 courses · 0 providers
MDMAPsilocybinRetention and engagement skills
Given the risk of high attrition, facilitators need strong engagement and follow-up skills. The protocol explicitly notes the importance of respecting time commitments, tracking procedures, and strong interpersonal skills of study personnel.
5 care stages · 2 guidelines · 0 courses · 0 providers
5-MeO-DMTKetamineSession pacing and timing
Therapists must pace the day appropriately, from early dosing to flexible termination, avoiding premature ending that could destabilize the subject. The handbook presents timing as an active facilitative skill rather than a logistical detail.
2 care stages · 2 guidelines · 0 courses · 0 providers
5-MeO-DMTLSDSupport patients with moderate-to-severe major depressive disorder
Therapists/facilitators require knowledge of treating patients with moderate-to-severe major depressive disorder in the context of psychedelic-assisted therapy. The target population in the trial establishes disorder-specific clinical knowledge needs.
1 care stage · 2 guidelines · 0 courses · 0 providers
DMT / AyahuascaLSDTraining in PAP and protocol manual adherence
Therapists must be specifically trained in psilocybin-assisted psychotherapy and in the study’s manualized procedures. Competence includes familiarity with the therapeutic model and difficult-state management guidance.
4 care stages · 2 guidelines · 0 courses · 0 providers
PsilocybinTreatment-condition matching and support
Deliver comparable behavioral support across psilocybin and NRT conditions while respecting protocol differences. Facilitators must maintain treatment fidelity and avoid bias toward one arm.
2 care stages · 2 guidelines · 0 courses · 0 providers
KetaminePsilocybinWorking with family/collateral supports
The protocol expects involvement of relatives in follow-up, indicating a facilitator competency in engaging collateral supports. This helps verify outcomes and sustain recovery monitoring.
4 care stages · 2 guidelines · 0 courses · 0 providers
IbogaineKetamineConfidentiality and trust maintenance
The course explicitly discusses confidentiality, especially in underground practice and with anonymous practitioners. Learners are expected to understand confidentiality as a core part of maintaining safe and effective psychedelic care relationships.
5 care stages · 1 guidelines · 1 courses · 1 providers
LSDAddress transference and countertransference openly
Therapists should be aware of transference and countertransference, which may be intensified in non-ordinary states. They are expected to respond with honesty, self-awareness, and openness rather than leaving important relational dynamics unspoken.
1 care stage · 1 guidelines · 0 courses · 0 providers
MDMAAssess and treat anxiety related to life-threatening disease
The intervention targets anxiety associated with life-threatening diseases, so therapists need knowledge of the psychological burden of severe medical illness and the clinical presentation of anxiety in this population. They must be able to formulate treatment needs in medically ill patients.
1 care stage · 1 guidelines · 0 courses · 0 providers
LSDBoundary management in a dual-role therapeutic model
Navigate the combination of psychedelic support and AUD therapy while preserving clear therapeutic boundaries. The facilitator must deliver supportive care without role confusion or undue influence.
3 care stages · 1 guidelines · 0 courses · 0 providers
DMT / AyahuascaClinical judgment on treatment optimization
Uses observed patient response to help optimize how ketamine-assisted psychotherapy is administered. Informs future clinical decisions about approach and dosing strategy.
1 care stage · 1 guidelines · 0 courses · 0 providers
KetamineCompetence in specialized psychedelic therapy training
The protocol implies that facilitators should have specific psychiatric, psychotherapeutic, or psycholytic therapy training relevant to altered-state treatment. Specialized experience supports safe and effective delivery of LSD-assisted psychotherapy.
1 care stage · 1 guidelines · 0 courses · 0 providers
LSDCoordinate adjunctive ketamine or active placebo with psychotherapy timing
Facilitators and treating clinicians must understand and operationalize the study-specific timing between infusions and exposure sessions. This includes aligning infusion administration 24 hours before PE sessions during the first 3 weeks.
2 care stages · 1 guidelines · 0 courses · 0 providers
KetamineCultural and values-sensitive therapy
Explores participant values, including spiritual values, in a respectful way that supports behavior change. Integrates meaning-making without imposing therapist beliefs.
2 care stages · 1 guidelines · 0 courses · 0 providers
PsilocybinDeliver culturally sensitive care
Therapists must adapt their practice to diverse cultural and linguistic contexts. Cultural sensitivity is important for trust, communication, and consistency across sites.
1 care stage · 1 guidelines · 0 courses · 0 providers
PsilocybinDyadic facilitation and gender-balanced therapeutic presence
Experimental sessions are conducted by a male physician-investigator and an experienced female nurse, indicating competency in co-therapy, complementary roles, and continuous therapeutic presence.
1 care stage · 1 guidelines · 0 courses · 0 providers
MDMAEthical honesty and transparency in management
The handbook emphasizes straightforward, honest dealing with subjects, especially when they feel suspicious, followed, or influenced. Trust is built by avoiding manipulation, deception, or concealed motives.
1 care stage · 1 guidelines · 0 courses · 0 providers
LSDGroup facilitation and relational process leadership
Therapists and facilitators must be able to guide intentional group process in a way that supports safety, connection, and meaningful change. This includes managing both large- and small-group formats and maintaining a relationally anchored therapeutic environment.
2 care stages · 1 guidelines · 0 courses · 0 providers
KetamineIndividual versus group modality selection
Therapists should understand the distinct advantages, limitations, and indications of individual and group methods. Clinical judgment is required to choose format, order, staffing, and group composition.
1 care stage · 1 guidelines · 0 courses · 0 providers
LSDIntegration of Western and Indigenous knowledge systems
Facilitators must understand the model's intentional weaving of Western clinical frameworks with Indigenous knowledge systems. This requires respectful, non-tokenistic integration grounded in explicit values rather than superficial cultural inclusion.
1 care stage · 1 guidelines · 0 courses · 0 providers
KetamineMaintain a post-session safety net
Therapists must provide continuity, availability, and clear support structures after MDMA sessions to reduce anxiety and manage emerging difficulties. This safety net extends beyond the dosing day.
5 care stages · 1 guidelines · 0 courses · 0 providers
MDMAMusic selection and management
Use music intentionally as part of the therapeutic environment and processing sequence. Music should support, not direct, the patient’s unfolding internal experience.
2 care stages · 1 guidelines · 0 courses · 0 providers
MDMANonjudgmental acceptance with firm boundaries
Therapists are expected to offer deep acceptance of the person while not necessarily endorsing all acts or rationalizations. The handbook portrays therapeutic acceptance as compatible with clear interpersonal limits and reality-based feedback.
1 care stage · 1 guidelines · 0 courses · 0 providers
LSDParticipant preparation for medication adherence
Prepare participants to correctly use nicotine replacement therapy when assigned to the control arm. Facilitators must provide education, dosing instructions, and side-effect guidance.
2 care stages · 1 guidelines · 0 courses · 0 providers
PsilocybinPatient selection and indication awareness
Knowledge of the patient populations and symptom profiles for which KAP may be considered, particularly depression, anxiety, PTSD, and treatment-resistant presentations. The article highlights benefit across a wide variety of diagnoses, with notable improvement in depression and anxiety.
1 care stage · 1 guidelines · 0 courses · 0 providers
KetamineShort-duration session management
The facilitator should be able to manage a brief but intense treatment window. The source suggests a shorter-acting psychedelic may enable rapid onset of response and reduce burden compared with longer-acting agents.
3 care stages · 1 guidelines · 0 courses · 0 providers
5-MeO-DMTSocial support assessment and guidance
Therapists must assess the participant’s social support network and help plan appropriate use of supportive relationships during treatment. They should guide participants about the potential benefits and risks of sharing their experiences with others.
4 care stages · 1 guidelines · 0 courses · 0 providers
MDMAStructure a therapeutic learning environment
The therapist’s core role is to structure conditions that maximize the subject’s opportunity for self-understanding and change, tailored to the subject, therapist, and relevant environmental variables. The handbook repeatedly frames therapeutic effectiveness as depending on how well the clinician shapes the setting and process rather than directing content for the patient.
1 care stage · 1 guidelines · 0 courses · 0 providers
LSDSupervision and self-reflection
Use supervision, debriefing, and personal reflection to manage the intensity and complexity of IMAP work. Therapists need support to stay effective and ethically grounded.
1 care stage · 1 guidelines · 0 courses · 0 providers
MDMASupport for repeated-session care planning
Because the protocol compares single versus repeated KPT, therapists must be able to prepare patients for sequential sessions and maintain continuity across a month-spaced treatment course. This includes pre-session counseling and repeated integration work.
2 care stages · 1 guidelines · 0 courses · 0 providers
KetamineSupport multiplicity without pathologizing
Therapists should understand multiplicity, parts, selves, and related phenomena as often normal and especially relevant in trauma work. They must respond without pathologizing the participant’s awareness of different parts of self.
1 care stage · 1 guidelines · 0 courses · 0 providers
MDMASupport relationship and support-system integration
Therapists must help participants navigate interpersonal shifts, disclosure decisions, and support-system responses during healing. They should anticipate misunderstanding, family-system changes, and new relational capacities.
2 care stages · 1 guidelines · 0 courses · 0 providers
MDMATherapeutic use of equipment and stimuli
The handbook describes skillful use of music, images, mirrors, and simple comforts to guide attention, reduce distress, and deepen self-examination. These supports are not incidental but part of the structured method.
1 care stage · 1 guidelines · 0 courses · 0 providers
LSDTraining and scope of practice in KAP delivery
The protocol specifies that therapists require relevant professional qualifications and dedicated training in both the CBT manual and ketamine-assisted psychotherapy adaptations. Competent delivery depends on staying within scope and using protocol-specific training.
1 care stage · 1 guidelines · 0 courses · 0 providers
KetamineTrauma-informed and emotionally sensitive interviewing
Conducts evaluations and psychotherapy with sensitivity to distress, moral injury, grief, and burnout. The therapist must avoid unnecessary burden while still collecting required data.
1 care stage · 1 guidelines · 0 courses · 0 providers
PsilocybinTrauma-informed case conceptualization
Understand PTSD, complex trauma, avoidance, dissociation, attachment disruption, and moral injury in order to interpret clinical material accurately and flexibly. Diagnosis-specific knowledge informs judgment without making the treatment protocol rigid.
1 care stage · 1 guidelines · 0 courses · 0 providers
MDMATrauma-informed, non-threatening interviewing
Use a caring, natural, and non-threatening interview style to assess psychiatric and psychological domains. The protocol emphasizes normalization, reduction of guilt, symptom exaggeration techniques, and a logical flow that facilitates rapport.
2 care stages · 1 guidelines · 0 courses · 0 providers
KetamineWithdrawal and craving support
Monitor and address nicotine withdrawal symptoms and smoking urges across the treatment window. Facilitators help participants manage discomfort and sustain abstinence through high-risk periods.
2 care stages · 1 guidelines · 0 courses · 0 providers
PsilocybinPsychedelic therapy foundation
Cluster covering 7 related competencies including: Psychedelic therapy foundation, Psychedelic therapy foundations, Psychedelic practice fundamentals.
4 care stages · 0 guidelines · 6 courses · 5 providers
KetamineMDMAPsilocybinNeurobiology of non-ordinary states
Teaches the neurobiological basis of psychedelic and non-ordinary states, including default mode, salience, fear, and related brain-network models. The competency links altered-state phenomenology with therapeutic mechanisms and clinical implications.
5 care stages · 0 guidelines · 4 courses · 4 providers
KetaminePsilocybinComplex-case support and ethics-based clinical judgment
Teaches work with clinically complex contexts such as trauma, palliative care, and other nuanced presentations where ethical judgment, scope discipline, careful assessment, and individualized support are required.
3 care stages · 0 guidelines · 2 courses · 1 providers
PsilocybinApprenticeship and mentor shadowing
The program includes supervised apprenticeship hours with pre-approved mentors. Learners are expected to observe, assist, and translate training into supervised practice.
6 care stages · 0 guidelines · 1 courses · 1 providers
PsilocybinAssessment and intake
The curriculum includes practical assessment work and use of intake templates and assessment forms. Students learn to evaluate client fit and tailor support based on client goals and needs.
3 care stages · 0 guidelines · 1 courses · 1 providers
Debriefing and reflective practice
The practicum includes retreat team debriefs, supervisor meetings, and assessment presentations. This signals an expectation that learners can reflect on practice, receive feedback, and integrate learning.
6 care stages · 0 guidelines · 1 courses · 1 providers
Human-centred, experiential facilitation
The overall program emphasizes experiential, relational, and community-grounded learning, including retreat and practicum components. Learners are expected to develop a grounded facilitation presence in addition to theory.
4 care stages · 0 guidelines · 1 courses · 1 providers
MDMAPsilocybinPeer consultation and collaborative learning
Vital emphasizes study groups, peer interaction, and faculty-led sessions. Learners are expected to collaborate with others, receive feedback, and improve their practice through community learning.
4 care stages · 0 guidelines · 1 courses · 1 providers
Personal growth work and self-exploration
Students are expected to complete personal growth work outside the program, including therapy, guided entheogenic work, or meditation retreats. This signals the importance of self-awareness and personal preparation for facilitation work.
2 care stages · 0 guidelines · 1 courses · 1 providers
PsilocybinSupporting diverse spiritual and community contexts
The program states it prepares facilitators to address the needs of clients, patients, or community members from diverse faith traditions and communities of origin. Learners are expected to adapt facilitation to varied settings and worldviews.
5 care stages · 0 guidelines · 1 courses · 1 providers
Bilingual and bicultural engagement
The page explicitly signals the value of bilingual and bicultural heritage as a foundation for practice. This points to competence in communicating and relating across language and cultural context.
4 care stages · 0 guidelines · 0 courses · 1 providers
Other categories
Explore the rest of the competency taxonomy.